By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Solanbridge Group, Inc.

Solanbridge Group, Inc. (SLNX)

OTC Currency in USD
$0.00
$0.00
+400.00%
Last Update: 29 Aug 2025, 00:00
$476.00K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

SLNX Stock Price Chart

Explore Solanbridge Group, Inc. interactive price chart. Choose custom timeframes to analyze SLNX price movements and trends.

SLNX Company Profile

Discover essential business fundamentals and corporate details for Solanbridge Group, Inc. (SLNX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

29 Jun 2007

Employees

CEO

David J. Cutler

Description

Solanbridge Group, Inc. intends to produce and sell medical marijuana in Nova Scotia, Canada. It also focuses on the development and sale of CBD-infused products in Nevada, California, and Colorado. The company was founded in 2000 and is headquartered in The Woodlands, Texas.

SLNX Financial Timeline

Browse a chronological timeline of Solanbridge Group, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

SLNX Stock Performance

Access detailed SLNX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run